Fig 1From: Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancerSurvival by residual tumor status after interval debulking surgery. a Progression free survival and b overall survival in each residual tumor status (R0, no residual tumor. R1, residual tumor)Back to article page